Bellwether trials involving allegations of uncontrollable gambling and other compulsive behaviors from the antipsychotic drug Abilify (generic: aripiprazole) are scheduled to begin in June in U.S. District Court in Florida.
Free Confidential Lawsuit Evaluation: If you or a loved one had compulsive behavior after taking Abilify, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
April 23, 2018 – In an order (PDF) issued on March 12, U.S. District Judge Casey Rodgers granted a joint proposal submitted by parties on both sides of the Abilify litigation to extend certain discovery deadlines. However, Casey denied a motion to postpone the Daubert hearings, so the first bellwether trials are still scheduled to kick off in early June.
Plaintiffs in Abilify lawsuits allege that Bristol Myers-Squibb and Otsuka Pharmaceuticals, the companies that jointly manufacture and market the drug, knew or should have known about the link between Abilify and gambling addictions, which may emerge shortly after starting the drug and increase with higher dosages. If proper warnings on Abilify had been provided on the labeling, plaintiffs claim they may have avoided catastrophic financial losses by not betting their entire life savings on a single hand of roulette.
Additionally, suits claim that the manufacturers withheld information from the public and medical communities in an attempt to maximize profits, and were well aware of Abilify’s potential to cause uncontrollable urges to gamble, shop, engage in risky sexual activity or other destructive behavior. While the outcome of bellwether trials are not binding to the class of plaintiffs, they are intended to gauge how juries and judges are likely to react to the common evidence.
Abilify is developed in the U.S. in a joint partnership between Bristol-Myers Squibb and Otsuka Pharmaceuticals, the defendants named in about 600 lawsuits alleging failure to warn about the risk of uncontrollable compulsive behaviors associated with the medication. This mountain of litigation is sure to grow even larger in the coming weeks and months, as the spotlight once again focuses on Abilify and its perceived side effects. Many legal experts are predicting an MDL of 1,000 cases or more by the time all is said and done.
Do I Have an Abilify Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Abilify lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Case Evaluation: Again, if you had severe side effects from Abilify, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.